{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:40:25Z","timestamp":1788925225534,"version":"build-2803163510"},"reference-count":49,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,4,3]],"date-time":"2007-04-03T00:00:00Z","timestamp":1175558400000},"content-version":"vor","delay-in-days":4171,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Histopathology"],"published-print":{"date-parts":[[1995,11]]},"abstract":"<jats:p>The proliferative activity of the haematopoietic and plasma cells in bone marrow was evaluated under normal and neoplastic conditions, by means of a sequential double immunostaining technique, using monoclonal antibody MIB\u20101 recognizing the cell proliferation\u2010associated nuclear antigen Ki\u201067, and antibodies against glycophorin\u2010C, myeloperoxidase, factor VIII\u2010related antigen, and immunoglobulin light chains. Fifty\u2010eight B5 fixed, paraffin\u2010embedded bone marrow biopsies were analysed, including 11 normal controls, 10 cases of myelodysplasia, 14 cases of chronic myeloproliferative disorder, eight cases of acute non\u2010lymphoid leukaemia, and 15 cases of myeloma. In normal marrows, the highest proliferative activity was noticed in the erythroid cells (75% to 95%; mean 90%), in comparison with myeloid precursors (15% to 80%; mean 38%), and megakaryocytes (10% to 20%; mean 14%); no Ki\u201067 positive plasma cells were found. In all investigated haematological disorders, the expression of MIB\u20101 by erythroid cells was similar to that observed in controls. Similarly, the percentage of MIB\u20101+ myeloid precursors in chronic myeloproliferative disorders and myelodysplasia largely overlapped the values observed in normals, and comparable values were also found in the blast cells from acute non\u2010lymphoid leukaemia type M1 and M2. These findings suggest that the evaluation of either erythroid or myeloid proliferative activity is of little value in the differential diagnosis between these myeloproliferative disorders. By contrast, the obvious increase of Ki\u201067 expression of megakaryocytes in chronic myeloproliferative disorders, with labelling also of micro\u2010megakaryocytes, might sustain the diagnosis in controversial cases. Since cases of mature myeloma showed less than 2% of Ki\u201067 positive cells, evaluation of proliferative activity is of no value in the differential diagnosis with reactive plasmacytosis. The sequential double immunophenotyping for Ki\u201067 antigen and for haematopoietic cell lineage\u2010associated markers can be applied in a consistent manner to routine bone marrow biopsies to evaluate proliferating cells in normal and neoplastic conditions.<\/jats:p>","DOI":"10.1111\/j.1365-2559.1995.tb00302.x","type":"journal-article","created":{"date-parts":[[2007,4,3]],"date-time":"2007-04-03T14:40:37Z","timestamp":1175611237000},"page":"397-405","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Assessment of cell proliferation in normal and pathological bone marrow biopsies: a study using double sequential immunophenotyping on paraffin sections"],"prefix":"10.1111","volume":"27","author":[{"given":"W.","family":"PELLEGRINI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"FACCHETTI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"MAROCOLO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"SALVI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"CAPUCCI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"TIRONI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"ROSSI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,4,3]]},"reference":[{"key":"e_1_2_1_2_2","volume-title":"Textbook of Hematology","author":"Jandl JH.","year":"1987"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(87)90160-3"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1159\/000205651"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196406182702506"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1988.tb02368.x"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(91)90144-I"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V71.5.1201.1201"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.47.3.209"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1993.tb00156.x"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711660108"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711730103"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.43.3.184"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1993.tb00135.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1993.tb00174.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01606529"},{"key":"e_1_2_1_17_2","first-page":"164","article-title":"Evaluation of cell\u2010proliferation antibodies reactive in paraffin sections","volume":"2","author":"Kelleher L","year":"1994","journal-title":"Appl. Immunohistochem."},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/40.9.1354677"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910310104"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.47.6.524"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711680404"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V65.2.305.305"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.133.4.1710"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1990.tb00788.x"},{"key":"e_1_2_1_25_2","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1182\/blood.V74.5.1517.1517","article-title":"Nuclear oncoprotein expression as a function of lineage, differentiation stage, and proliferative status of normal hematopoeitic cells","volume":"74","author":"Kastan MB","year":"1988","journal-title":"Blood"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.990120108"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(92)90326-X"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/41.8.8331288"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(94)90074-4"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(94)90198-8"},{"key":"e_1_2_1_31_2","first-page":"860","article-title":"Assessment of cell proliferation in paraffin sections of normal bone marrow by the monoclonal antibodies Ki\u201067 and PCNA","volume":"7","author":"Budke H","year":"1994","journal-title":"Modern Pathology"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01606429"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1993.tb00154.x"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(93)90082-R"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-93-2-347"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01469046"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19831001)52:7<1190::AID-CNCR2820520711>3.0.CO;2-R"},{"key":"e_1_2_1_38_2","first-page":"65","article-title":"Flow cytometric analysis of cellular DNA in human acute nonlymphatic leukemias and dysmyelopoietic syndromes","volume":"22","author":"Maiolo AT","year":"1982","journal-title":"Cytometry"},{"key":"e_1_2_1_39_2","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood.V79.4.1037.bloodjournal7941037","article-title":"High expression of transforming Growth Factor\u2010\u03b2 long cell cycle times and a unique clustering of S\u2010phase cells in patients with acute promyelocytic leukemia","volume":"79","author":"Raza A","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.44.4.300"},{"key":"e_1_2_1_41_2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1182\/blood.V79.1.198.198","article-title":"Primary myelodysplastic syndromes diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies","volume":"79","author":"Mangi MH","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_42_2","first-page":"143","volume-title":"Tumors of the bone marrow. Atlas of Tumor Pathology. Third Series","author":"Brunning RD","year":"1993"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1988.00471.x-i1"},{"key":"e_1_2_1_44_2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood.V57.2.333.333","article-title":"The growth fraction of human myeloma cells","volume":"57","author":"Drewinko B","year":"1981","journal-title":"Blood"},{"key":"e_1_2_1_45_2","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1182\/blood.V70.4.932.932","article-title":"Delineation of a novel pre\u2010B cell component in plasma cell myeloma: immunochemical, immunophenotypic, genotypic, cytologic, cell culture and kinetics features","volume":"70","author":"Grogan TM","year":"1987","journal-title":"Blood"},{"key":"e_1_2_1_46_2","first-page":"30","article-title":"Initial bone marrow findings in multiple myeloma. Significance of plasma cell nodules","volume":"110","author":"Buss DH","year":"1986","journal-title":"Arch. Pathol. Lab. Med."},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/94.6.742"},{"key":"e_1_2_1_48_2","first-page":"1235","volume-title":"Neoplastic Hematopathology","author":"Grogan TM","year":"1992"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(94)90204-6"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/40.11.2154"}],"container-title":["Histopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2559.1995.tb00302.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2559.1995.tb00302.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T07:00:13Z","timestamp":1698303613000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2559.1995.tb00302.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,11]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1995,11]]}},"alternative-id":["10.1111\/j.1365-2559.1995.tb00302.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2559.1995.tb00302.x","archive":["Portico"],"relation":{},"ISSN":["0309-0167","1365-2559"],"issn-type":[{"value":"0309-0167","type":"print"},{"value":"1365-2559","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,11]]},"assertion":[{"value":"2007-04-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}